Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome
- 30 March 2009
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 9 (7) , 1982-1993
Abstract
Aggressive treatment with high‐dose atorvastatin reduces more effectively the incidence of cardiovascular events than moderate statin therapy. The mechanism of this benefit has not been fully elucidated. In order to know the potential effects of statin treatment on the protein expression of circulating monocytes in acute coronary syndrome (ACS) patients, a proteomic analysis of these cells was carried out by 2‐DE and MS. Twenty‐five patients with non‐ST‐elevation acute coronary syndrome (NSTEACS) were randomized, the fourth day after admission, to receive ATV 80 mg/dL (n = 14) or conventional treatment (CT) (n = 11), for two months. Blood was withdrawn at the end of the treatment, and monocytes were extracted for proteomic analysis and their protein expression patterns determined. Age, sex, total cholesterol, LDL, HDL, triglycerides, body mass index, presence of hypertension, diabetes, and smoking status were not significantly different between the two groups of patients. The expression of 20 proteins was modified by intensive ATV. Among the most relevant results stand out the normalization by intensive ATV treatment of the expression of proteins that modulate inflammation and thrombosis such as protein disulfide isomerase ER60 (PDI), Annexin I, and prohibitin, or that have other protective effects as HSP‐70. Thus, this approach shed light at the molecular level of the beneficial mechanisms of anti‐atherothrombotic drugs.Keywords
This publication has 55 references indexed in Scilit:
- H11 Kinase Prevents Myocardial Infarction by Preemptive Preconditioning of the HeartCirculation Research, 2006
- Atorvastatin Reduces the Expression of Prostaglandin E2 Receptors in Human Carotid Atherosclerotic Plaques and Monocytic CellsJournal of Cardiovascular Pharmacology, 2006
- Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: The modulating effect of statinsAtherosclerosis, 2005
- Association of Serum-Soluble Heat Shock Protein 60 With Carotid AtherosclerosisStroke, 2005
- S100A8 and S100A9 in Human Arterial WallJournal of Biological Chemistry, 2005
- Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One MonthStroke, 2005
- p27Kip1 and stathmin share the stage for the first timeTrends in Cell Biology, 2005
- Immune Activation in Chronic Heart FailureThe American Journal of Cardiology, 2005
- Anti-inflammatory and immunomodulatory effects of statinsKidney International, 2003
- Prohibitins act as a membrane‐bound chaperone for the stabilization of mitochondrial proteinsThe EMBO Journal, 2000